Luye Pharma Group Ltd Stock Singapore S.E.
Equities
LUYE
BMG5722Z1014
Pharmaceuticals
Sales 2024 * | 6.83B 941M 1.26B | Sales 2025 * | 7.81B 1.08B 1.44B | Capitalization | 10B 1.38B 1.85B |
---|---|---|---|---|---|
Net income 2024 * | 677M 93.28M 125M | Net income 2025 * | 965M 133M 178M | EV / Sales 2024 * | 1.84 x |
Net Debt 2024 * | 2.59B 357M 479M | Net Debt 2025 * | 2.41B 332M 446M | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.84% |
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
1st Jan change | Capi. | |
---|---|---|
+60.25% | 846B | |
+38.56% | 628B | |
-4.49% | 360B | |
+18.30% | 322B | |
+9.64% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+12.87% | 173B |